Teaming to drive the future of genomic medicine
Tender Summary
The I3S - INSTITUTO DE INVESTIGACAO E INOVACAO EM SAUDE DA UNIVERSIDADE DO PORTO in Belgium from Europe region has released this tender for Teaming to drive the future of genomic medicine Genomic medicine is transforming healthcare through precise personalized solutions that enhance patient outcomes However Portugal faces significant challenges including limited genomic sequencing fragmented clinical applications and a shortage of specialized talent i3S-HEALTH aims to address these issues by modernizing the Institute for Research and Innovation in Health i3S into a global Centre of Excellence in Genomic Medicine under the guidance of the European Molecular Biology Laboratory EMBL as an advanced partner i3S-HEALTH will establish a state-of-the-art Genomic Medicine Hub that uniquely integrates next-generation sequencing computational biology AI-driven bioinformatics and high-throughput functional genomics for new variants discovery to improve patient care This initiative will be Portugal s first multidisciplinary platform connecting advanced genomic research with clinical diagnostics Key expected outcomes will include expanded diagnostic capacity and accuracy trained specialists developing novel predictive algorithms for complex genetic conditions and identifying actionable multi-omics biomarkers i3S-HEALTH will enrich the genomic medicine landscape in Portugal and Europe by strategically engaging the scientific community to accelerate genomic discoveries and foster high-impact collaborations with healthcare providers improving clinical decision-making through better diagnostics and personalized patient care It will also collaborate with industry to co-develop innovative diagnostics and therapeutics in public-private partnerships Increased revenues from advanced diagnostic services strategic industry partnerships new projects IP development and the launch of genomics spin-offs will ensure sustainability beyond the project i3S-HEALTH will directly strengthen national R I performance in genomic medicine positioning i3S as a leading European center for innovation and excellence in genomic healthcare research with tender notice no. 101250351 published on 24 Aug 2026. The tender is due to expire on 31 Dec 2032. This tender is sourced from Cordis and is eligible for suppliers interested in Genotyping, Proteomics, Molecular diagnostic, Sequencing. Interested bidders can obtain further information including complete bid documents or ways to participate by registering on Tender Impulse and referencing via Tender Impulse ID 14500586.
Tender Details
Tender NoticeTI Ref: 14500586
Tender Notice No
101250351
Tender Organisation
I3S - INSTITUTO DE INVESTIGACAO E INOVACAO EM SAUDE DA UNIVERSIDADE DO PORTO
Tender Sector
Tender Service
Worldwide
Tender Region
Tender Project Location
Tender CPV
33200000 : Genotyping33100005 : Proteomics98127347 : Molecular diagnostic331000001 : Sequencing
Tender Source
Cordis
Tender Document Type
Tender Notice
Tender Deadline
31 Dec 2032 2304 days left
Tender Description
Teaming to drive the future of genomic medicine Genomic medicine is transforming healthcare through precise personalized solutions that enhance patient outcomes However Portugal faces significant challenges including limited genomic sequencing fragmented clinical applications and a shortage of specialized talent i3S-HEALTH aims to address these issues by modernizing the Institute for Research and Innovation in Health i3S into a global Centre of Excellence in Genomic Medicine under the guidance of the European Molecular Biology Laboratory EMBL as an advanced partner i3S-HEALTH will establish a state-of-the-art Genomic Medicine Hub that uniquely integrates next-generation sequencing computational biology AI-driven bioinformatics and high-throughput functional genomics for new variants discovery to improve patient care This initiative will be Portugal s first multidisciplinary platform connecting advanced genomic research with clinical diagnostics Key expected outcomes will include expanded diagnostic capacity and accuracy trained specialists developing novel predictive algorithms for complex genetic conditions and identifying actionable multi-omics biomarkers i3S-HEALTH will enrich the genomic medicine landscape in Portugal and Europe by strategically engaging the scientific community to accelerate genomic discoveries and foster high-impact collaborations with healthcare providers improving clinical decision-making through better diagnostics and personalized patient care It will also collaborate with industry to co-develop innovative diagnostics and therapeutics in public-private partnerships Increased revenues from advanced diagnostic services strategic industry partnerships new projects IP development and the launch of genomics spin-offs will ensure sustainability beyond the project i3S-HEALTH will directly strengthen national R I performance in genomic medicine positioning i3S as a leading European center for innovation and excellence in genomic healthcare research
Tender Bidding Type
Tender Document
Frequently Asked Questions About This Tender
Who has issued this tender, and what is it for?
The tender has been issued by I3S - INSTITUTO DE INVESTIGACAO E INOVACAO EM SAUDE DA UNIVERSIDADE DO PORTO in Belgium. Such a type of tender falls under Genotyping, Proteomics, Molecular diagnostic, Sequencing, within the Healthcare & Medical sector, and is listed on Tender Impulse under notice number 101250351.
What are the key dates for this tender?
The notice was published on 24 Aug 2026 and submissions close on 31 Dec 2032. Late bids are rarely accepted in public procurement, so aim to have your documents ready several days before the closing date.
Which CPV codes apply to this tender?
It is classified under CPV codes 33200000, 33100005, 98127347, 331000001, which correspond to Genotyping, Proteomics, Molecular diagnostic, Sequencing. If your company supplies these products or services, these are the codes to save in your alert profile so no matching tender passes you by.
Can I submit my bid for this tender to Tender Impulse?
No - and this matters. Tender Impulse is a tender aggregation and alert service: we collect procurement notices from official sources around the world and list them in one place. We do not receive, forward or evaluate bids. Your bid for this tender must be submitted directly to I3S - INSTITUTO DE INVESTIGACAO E INOVACAO EM SAUDE DA UNIVERSIDADE DO PORTO, using the method described in the original tender document, before 31 Dec 2032. Tender Impulse provides complete assistance in submitting all bids posted on its website.
How do I get the bid documents and participation details?
Request a live demo on Tender Impulse and our tender experts will walk you through this listing, share the available documents, and explain how to submit your bid to I3S - INSTITUTO DE INVESTIGACAO E INOVACAO EM SAUDE DA UNIVERSIDADE DO PORTO. Subscribers also receive help with registration requirements and, where needed, translation of non-English notices - but the submission itself always goes from you to the buyer.
How can I find more tenders like this in Belgium?
There are currently 3861 live tenders of 51720 total tenders from Belgium on Tender Impulse. You can browse them on our Belgium tenders page, or save a search combining Belgium with CPV codes 33200000, 33100005, 98127347, 331000001 - we will then email you every new match on the day it is published.
How to prepare for this bid?
Suppliers must verify technical specifications, the delivery schedules and any other intrinsic details as provided in the complete bid documents before deciding to submit their bids. All necessary certifications and supplier registrations must be undertaken before participation.
Is this tender beneficial for me?
The procurement is applicable to companies in the Genotyping, Proteomics, Molecular diagnostic, Sequencing and related industries. If you belong to this industry, you can review the technical documents before assessing your relevance to your company.
What is the procurement trend for Teaming to drive the future of genomic medicine?
The public procurement trends for Teaming to drive the future of genomic medicine can be assessed by viewing historical data and buying patterns for this product. Subscribed members can view and even download reports of tenders released in the past for their market research. This shall allow them to carefully prepare a compelling bid.
Explore More Genotyping, Proteomics, Molecular diagnostic, Sequencing Tenders in Belgium, Europe Region and Worldwide
Looking for more tenders like this one in Genotyping, Proteomics, Molecular diagnostic, Sequencing? With millions of global procurement opportunities and new tenders added daily, Tender Impulse is your gateway to international and local contracting success. Whether you're targeting the Healthcare & Medical sector in Belgium, or expanding across regions, we provide live, accurate and relevant updates every day.
Our platform sources tenders from national and local government portals, international development and funding agencies, municipal corporations, state authorities, NGOs, education ministries and public-private partnerships.
Daily Tender Updates Across 190+ Countries
Every day we add hundreds of new RFPs, RFQs, EOIs and contract awards across multiple sectors and geographies. This tender from Belgium is just a sample of what's available right now - there are currently 3,861 live Belgium tenders to explore.
Search Smarter with CPV and Industry Matching
Each listing is categorised using CPV codes such as 33200000, 33100005, 98127347, 331000001, enabling precise filtering by tender type, location, industry, deadline and issuing organisation.
Start Your Tender Journey
Request a free live demo to unlock tenders customised to your sector, country and CPV categories - with alerts, documents and submission support.
